Colombia on the Verge of Legalizing Dry Cannabis Flower: A Long-Awaited Step for Medical Patients

Colombia, a pioneer in medical cannabis legalization in Latin America, is on the cusp of a major shift in its cannabis policy. A new draft decree proposes allowing the sale of dry cannabis flower, a long-awaited change for patients who have been restricted to compounded formulations and other products. This move, however, faces regulatory hurdles and scientific concerns, potentially delaying access to dry flower for patients by at least a year and a half.

Global Hospital Furniture Market: Rising Demand Driven by Aging Population and Technological Advancements

The global hospital furniture market is poised for significant growth, driven by factors such as an aging population, increased chronic diseases, and advancements in medical technology. This comprehensive analysis by Transparency Market Research highlights key market trends, growth drivers, and regional dynamics, providing valuable insights for stakeholders in the hospital furniture industry.

UK Medical Marijuana Market Booms: Releaf Partners with Glass Pharms in Landmark Deal

Releaf, a leading UK medical marijuana provider, has entered into a major partnership with domestic cannabis producer Glass Pharms, marking a significant milestone for the UK medical cannabis industry. This deal, the largest of its kind in the UK, signifies the growing acceptance of medical cannabis as a legitimate healthcare solution and will ensure a reliable and consistent supply of high-quality medical cannabis for patients.

King Faisal Specialist Hospital: A Beacon of Medical Excellence for International Patients

King Faisal Specialist Hospital and Research Centre (KFSHRC) is rapidly becoming a leading destination for medical tourism, attracting patients from around the world with its advanced treatments, cutting-edge technology, and specialized medical expertise. With its focus on innovation and patient-centric care, KFSHRC is solidifying its position as a global hub for specialized healthcare.

Quest Diagnostics (DGX) Earnings Preview: What to Expect on October 22nd

Quest Diagnostics, a leading provider of diagnostic testing, is set to release its Q3 2024 earnings report on October 22nd. Analysts anticipate strong results with an EPS of $2.27, and investors will be keen to see if the company surpasses estimates and provides positive guidance for the upcoming quarter. This article provides an in-depth analysis of Quest Diagnostics’s historical performance, analyst sentiment, and peer comparisons, offering insights for investors ahead of the earnings release.

Bernie Sanders Highlights Link Between Economic Hardship and Shorter Lifespans for Working Class

Senator Bernie Sanders (I-Vt.) has once again drawn attention to the stark disparities in life expectancy between the wealthy and the working class in the United States. He shared his personal experience of growing up in a family struggling to make ends meet, and how the stresses of multiple jobs, unaffordable healthcare, and the constant threat of eviction contribute to a shorter lifespan for many Americans. Sanders’ comments highlight a growing concern about economic inequality and its impact on public health.

Scroll to Top